HR 6575 · 115th Congress 2017–2019, ended

Medicare Prescription Drug Savings and Choice Act of 2018

Latest action · Aug 13, 2018 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJul 26, 2018
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Medicare Prescription Drug Savings and Choice Act of 2018

This bill requires the Centers for Medicare & Medicaid Services (CMS) to offer one or more Medicare-operated prescription drug plan options under the Medicare prescription drug benefit.  In doing so, the CMS must: (1) negotiate prices with drug manufacturers; (2) establish an appeals process for denials of plan benefits, including the option for external review and determination by an independent entity; and (3) establish and apply a formulary and formulary incentives. In general, a Medicare-operated drug plan must meet the same requirements as apply to any other prescription drug plan.

Cosponsors

Members who signed on, in the order they did.

No cosponsors are on file for this measure.

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Jul 26, 2018
Health Subcommittee
Referred Jul 27, 2018
HouseWays and Means Committee
Referred Jul 26, 2018
Health Subcommittee
Referred Aug 13, 2018

Actions 4

Everything that happened, newest first.

  1. Aug 13, 2018Referred to the Subcommittee on Health.
  2. Jul 27, 2018Referred to the Subcommittee on Health.
  3. Jul 26, 2018Introduced in House
  4. Jul 26, 2018Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Pursuant to Article I, Section 8, Clause 3 of the United States Constitution

The sponsor’s statement, as printed in the Congressional Record, vol. 164, no. 126, July 26, 2018, page H7726.

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 1775Prescription Reduction in Costs for Everyone (PRICE) Act of 2017Related billApr 5, 2017
HR 3261Medicare Prescription Drug Savings and Choice Act of 2015Reintroduction ofAug 6, 2015

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend part D of title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program.
Short Titles as Introduced
Medicare Prescription Drug Savings and Choice Act of 2018

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jul 26, 2018Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.